Literature DB >> 12216027

Does Chiari osteotomy compromise subsequent total hip arthroplasty?

A Hashemi-Nejad1, F S Haddad, K M Tong, S K Muirhead-Allwood, A Catterall.   

Abstract

We compared 28 total hip arthroplasties done in dysplastic hips after previous Chiari osteotomy (group I) with a well-matched control group of 50 primary procedures (group II) done during the same period at an average follow-up of 5 years (range, 25-199 months). Group I required significantly less acetabular augmentation, had significantly shorter operative times, had less intraoperative blood loss, and had fewer complications than group II. There was no significant difference between the 2 groups in terms of clinical or radiographic outcome. Total hip arthroplasty after a successful Chiari osteotomy leads to medium-term results similar to those of other dysplastic hips. In our experience, less bone grafting was required, better coverage of the cup by host-bone was obtained, and the center of motion of the hip was more anatomic. Chiari osteotomy may delay the need for total hip arthroplasty, may facilitate acetabular reconstruction, and does not seem to compromise the medium-term clinical or radiographic outcome. Copyright 2002, Elsevier Science (USA).

Entities:  

Mesh:

Year:  2002        PMID: 12216027     DOI: 10.1054/arth.2002.31974

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  12 in total

1.  Effect of prior Salter or Chiari osteotomy on THA with developmental hip dysplasia.

Authors:  Kenji Tokunaga; Nadim Aslam; Rad Zdero; Emil H Schemitsch; James P Waddell
Journal:  Clin Orthop Relat Res       Date:  2010-05-11       Impact factor: 4.176

2.  Chiari pelvic osteotomy in the treatment of adolescent hip disorders: possibilities, limitations and complications.

Authors:  Zoran Vukasinovic; Dusko Spasovski; Nemanja Slavkovic; Zoran Bascarevic; Zorica Zivkovic; Branislav Starcevic
Journal:  Int Orthop       Date:  2010-09-28       Impact factor: 3.075

3.  Triple osteotomy of the pelvis for Legg-Calve-Perthes disease: a mean fifteen year follow-up.

Authors:  Régis Pailhé; Etienne Cavaignac; Jérôme Murgier; Jean Philippe Cahuzac; Jerôme Sales de Gauzy; Franck Accadbled
Journal:  Int Orthop       Date:  2015-02-03       Impact factor: 3.075

4.  The effect of previous pelvic or proximal femoral osteotomy on the outcomes of total hip arthroplasty in patients with dysplastic coxarthrosis.

Authors:  Fahri Erdoğan; Ata Can
Journal:  Acta Orthop Traumatol Turc       Date:  2020-01       Impact factor: 1.511

5.  Total hip arthroplasty after previous rotational acetabular osteotomy.

Authors:  Takahito Yuasa; Katsuhiko Maezawa; Masahiko Nozawa; Kazuo Kaneko
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-06-22

6.  High survival of dome pelvic osteotomy in patients with early osteoarthritis from hip dysplasia.

Authors:  Takashi Sakai; Takashi Nishii; Masaki Takao; Kenji Ohzono; Nobuhiko Sugano
Journal:  Clin Orthop Relat Res       Date:  2012-02-22       Impact factor: 4.176

7.  The results of Chiari pelvic osteotomy in adolescents with a brief literature review.

Authors:  Mohsen Karami; Franck Fitoussi; Brice Ilharreborde; Georges-François Penneçot; Keyvan Mazda; Henri Bensahel
Journal:  J Child Orthop       Date:  2008-01-03       Impact factor: 1.548

Review 8.  Total hip arthroplasty after pelvic osteotomy for acetabular dysplasia: A systematic review.

Authors:  Jacob Shapira; Shawn Annin; Philip J Rosinsky; David R Maldonado; Ajay C Lall; Benjamin G Domb
Journal:  J Orthop       Date:  2021-04-21

9.  Influence of shelf acetabuloplasty on the outcomes of total hip arthroplasty in hips with dysplasia: a case-control study.

Authors:  Kevin Benad; Pierre Martinot; Julien Dartus; Julien Girard; Sophie Putman; Henri Migaud
Journal:  Int Orthop       Date:  2022-02-03       Impact factor: 3.075

10.  [The Chiari osteotomy in the management of hip dysplasia in the adult: apropos of 9 cases].

Authors:  Mohammed Shimi; Hicham Mahdane; Atif Mechchat; Abedelhalim El Ibrahimi; Abedelmajid El Mrini
Journal:  Pan Afr Med J       Date:  2013-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.